Catalent throws down $175M on yet another manufacturing expansion

SourceFierce Pharma
Date Published05/19/2022
Author NameFraiser Kansteiner
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Catalent
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):277
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2024
Capital investment ($):175
City reshored to:Winchester
State(s) reshored to:KY
If relevant, work nearshored to:-
Product(s) reshoredoral medicines
What domestic positive factors made reshoring more attractive?Lead time/Time to market, Other, COVID-19
Find Reshoring Articles